pharma-company /Medicinal products /Active ingredients

Rx · PZN 12359918

CINQAERO 10 mg/ml 25 mg concentrate for preparation of a solution for infusion

German trade nameCINQAERO 10 mg-ml 25 mg Konzentrat zur Herstellung einer Infusionslösung

Active ingredientReslizumabPharmaceutical formConcentrate for solution for infusion

Only sporadically available

1.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €116

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for CINQAERO 10 mg/ml 25 mg concentrate for preparation of a solution for infusion.

Review purchasing terms

CINQAERO 10 mg/ml 25 mg concentrate for preparation of a solution for infusion contains the active ingredient Reslizumab and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 12359918). The pharma availability index for German wholesale stands at 1.6 out of 10 over the past 30 days – the pack was therefore only sporadically available.


CINQAERO 10 mg/ml 25 mg concentrate for preparation of a solution for infusion was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.